SEC EDGAR CompanyFacts fact · reporting period
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.: net_income
One fact, its scope and the complete path back to the official record.
Reported value
$-5.327M{"amount": -5327391, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"}- Metric
- net_income
- Period
- 2018-01-01 – 2018-06-30
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-19T17:22:55.656216+02:00
Raw response SHA-256
f7bde1a401b286c74a2fd824ee1df541…Official-identifier path
https://factanker.com/fact/sec/cik-0001697805/net-income/2018-06-30 (CIK, metric, reporting date)History
- supersedes {"amount": 142777, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001213900-18-010363)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.